Integrative approaches for stage III non-small cell lung cancer

Hot topics
Chairs: J. Vansteenkiste (Leuven, Belgium), L. Petruzelka (Prague, Czech Republic)
Aims: This symposium will explain how the management of stage III NSCLC has become an integrative approach in a multidisciplinary context with various disciplines. It will update the knowledge on the selection of candidates for multimodality treatment and the role of different treatment options in multimodality treatment. This symposium has been organised jointly with the CELCC (Central European Lung Cancer Conference). Target audience: Chest physicians, thoracic surgeons, radiation oncologists, medical oncologists.

Staging and restaging in the era of multimodality treatment G. Ostoros (Budapest, Hungary)
Role of chemotherapy in stage III non-small cell lung cancer (NSCLC): adjuvant or induction? G. Scagliotti (Orbassano, Italy)
Surgical multimodality treatment for stage III non-small cell lung cancer (NSCLC) R. Rami Porta (Barcelona, Spain)